Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Be The Match BioTherapies
investment firm
About
Be The Match BioTherapies® is built on the foundation established by our parent company.
Highlights
Details
- Operating Status
- Active
Investments
Number of Investments
Number of Lead Investments
5
0
Be The Match BioTherapies has made 5 investments. Their most recent investment was on
Oct 31, 2019, when Tmunity Therapeutics raised $75M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Oct 31, 2019
Tmunity Therapeutics
|
Series B | $75M | Biotechnology | — |
|
Apr 19, 2018
Tmunity Therapeutics
|
Series A | $35M | Biotechnology | — |
|
Apr 9, 2018
Magenta Therapeutics
|
Series C | $52M | Biotechnology | — |
|
Jan 23, 2018
Tmunity Therapeutics
|
Series A | $100M | Biotechnology | — |
|
May 2, 2017
Magenta Therapeutics
|
Series B | $50M | Biotechnology | — |
Employee Profiles
Number of Employee Profiles
2
Be The Match BioTherapies has 2 current employee profiles, including
Executive Chris McClain
Executive
Executive
Exits
Be The Match BioTherapies has had 2 exits. Be The Match BioTherapies most notable exits include Tmunity Therapeutics , Magenta Therapeutics
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Dec 20, 2022 | Tmunity Therapeutics | M&A | Biotechnology | Detail |
| Jun 20, 2018 | Magenta Therapeutics | IPO | Biotechnology | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
